MBOT
MBOT
NASDAQ · Health Care

Microbot Medical Inc

$1.25
-0.03 (-1.96%)
As of Sep 28, 10:21 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.70B
Net Income
-19,276,297
Gross Margin
82.8%
Profit Margin
-3,241.6%
Rev Growth
-6.1%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 82.8% 82.8% 62.2% 62.2%
Operating Margin -3,302.0% -2,971.8% 25.4% 22.6%
Profit Margin -3,241.6% -3,079.5% 17.2% 19.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.70B 1.81B 39.93M 46.94M
Gross Profit 1.40B 1.50B 24.82M 29.18M
Operating Income -55,998,648,641 -53,672,826,173 10.16M 10.59M
Net Income -19,276,297 -18,475,684 6.88M 9.06M
Gross Margin 82.8% 82.8% 62.2% 62.2%
Operating Margin -3,302.0% -2,971.8% 25.4% 22.6%
Profit Margin -3,241.6% -3,079.5% 17.2% 19.3%
Rev Growth -6.1% -6.1% -1.2% +14.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 23.03M 24.03M
Total Equity — — 67.54M 68.59M
D/E Ratio — — 0.34 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -21,096,463 -21,343,599 11.85M 15.12M
Free Cash Flow — — 3.52M 6.34M